Verogen, Inc. has been acquired by QIAGEN, the leading global provider of Sample to Insight solutions for molecular testing. Learn More
May 21, 2020

Why NGS, Why Now?

A Q&A with forensic laboratory directors on their decision to implement Verogen technology

Back to Webinars

For decades, forensic laboratories had limited choices for DNA analysis. A recent surge in approved technologies, notably next-generation sequencing (NGS), is providing laboratories with a variety of options to enhance capabilities. Amidst competing priorities, more laboratories are choosing to prioritize the implementation of Verogen NGS into their operational workflows.


Heather McKiernan

Director Center for Forensic Science Research and Education

Paul Misner

Biology Section Supervisor Indiana State Police Crime Lab

Ray Wickenheiser

Director New York State Police Crime Laboratory System